Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Three decades ago, cystic neoplasia of the pancreas were a relatively unknown and poorly classified tumor entity. Nowadays, they account for a large proportion of treated lesions in the field of pancreatic surgery. Depending on the cyst type and morphology, a conservative and observational treatment approach has become standard in selected cases. Cystic tumors of the pancreas include both, neoplastic cysts with a variable malignant potential and pseudocysts, which occur as a consequence of a previous pancreatis.
Contrast-enhanced multiphase computed tomographic (CT) scan, magnetic resonance imaging (MRI) with the possibility of non-invasive cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) are the key methods for detailed diagnostic evaluation and risk assessment of cystic pancreatic tumors.
Treatment of cystic tumors of the pancreas is safe according the published guidelines.
In patients with a confirmed diagnosis of the cyst subtype, pancreatic resection should be performed in surgically fit patients for intraductal papillary mucinous neoplasia (IPMN) with main duct and mixed type appearance, mucinous cystic neoplasia (MCN) and solid pseudopapillary neoplasia (SPN) regardless their size.
Laffan TA, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008;191(3):802–7. CrossRef
Brugge WR, et al. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351(12):1218–26. CrossRef
Ferrone CR, et al. Current trends in pancreatic cystic neoplasms. Arch Surg. 2009;144(5):448–54. CrossRef
Tanaka M, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97. CrossRef
Adsay NV. Cystic neoplasia of the pancreas: Pathology and biology. J Gastrointest Surg. 2008;12(3):401–4. CrossRef
Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148(4):824–48.e22. CrossRef
Crippa S, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: Lessons from 163 resected patients. Ann Surg. 2008;247(4):571–9. CrossRef
Fernandez-Del Castillo C. Mucinous cystic neoplasms. J Gastrointest Surg. 2007;12(3):411–3. CrossRef
Fernandez-Del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010;139(3):708–13. 713.e1–2. CrossRef
Sahora K, Fernandez-del Castillo C. Intraductal papillary mucinous neoplasms. Curr Opin Gastroenterol. 2015;31(5):424–9. CrossRef
Sahora K, et al. Branch duct intraductal papillary mucinous neoplasms: Does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013;258(3):466–75. CrossRef
Sahora K, et al. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: Implications of minimal involvement of the main pancreatic duct. Surgery. 2014;156(3):611–21. CrossRef
Mino-Kenudson M, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60(12):1712–20. CrossRef
Al-Haddad M, El Hajj II, Eloubeidi MA. Endoscopic ultrasound for the evaluation of cystic lesions of the pancreas. J Pancreas. 2010;11(4):299–309.
Park WG, et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas. 2011;40(1):42–5. CrossRef
Park WG, Chari ST. Management of pancreatic cystic neoplasms: Decision-making with limited information. Pancreatology. 2010;10(2/3):142–3. CrossRef
Tanaka M, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738–53. CrossRef
Sahora K, et al. Effects of comorbidities on outcomes of patients with Intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 2015;13(10):1816–23. CrossRef
Pergolini I, et al. Long-term risk of pancreatic malignancy in patients with branch duct Intraductal papillary mucinous neoplasm in a referral center. Gastroenterology. 2017;153(5):1284–1294.e1. CrossRef
Xourafas D, Tavakkoli A, Clancy TE, Ashley SW. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: Recurrence rates and postoperative imaging follow-up. Surgery. 2015;157(3):473–83. https://doi.org/10.1016/j.surg.2014.09.028. CrossRefPubMed
Thompson LD, et al. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: A clinicopathologic study of 130 cases. Am J Surg Pathol. 1999;23(1):1–16. CrossRef
- Management of cystic pancreatic lesions
Assoc. Prof. PD Dr. Klaus Sahora
Univ. Prof. Dr. Martin Schindl
- Springer Vienna
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II